Neonatology

Original Paper

Continuous Surveillance to Reduce Extended-Spectrum β-Lactamase Klebsiella pneumoniae Colonization in the Neonatal Intensive Care Unit

Benenson S.a · Levin P.D.b · Block C.a · Adler A.a · Ergaz Z.c · Peleg O.c · Minster N.a · Gross I.a · Schaffer K.c · Moses A.E.a · Cohen M.J.d

Author affiliations

aDepartment of Clinical Microbiology and Infectious Diseases, bDepartment of Anesthesiology and Critical Care Medicine, cNeonatal Intensive Care Unit, and dCenter for Clinical Quality and Safety, Hadassah – Hebrew University Medical Center, Jerusalem, Israel

Related Articles for ""

Neonatology 2013;103:155–160

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: May 10, 2012
Accepted: September 03, 2012
Published online: December 11, 2012
Issue release date: February 2013

Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 2

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Abstract

Background: Clinical illness caused by resistant bacteria usually represents a wider problem of asymptomatic colonization. Active surveillance with appropriate institution of isolation precautions represents a potential mechanism to control colonization and reduce infection. The neonatal intensive care unit (NICU) is an environment particularly appropriate for such interventions. Neonates are rarely colonized by resistant bacteria on admission and staff enthusiasm for infection control is high. Objective: To reduce extended-spectrum β-lactamase-producing Klebsiella pneumoniae (ESBL-KP) acquisition amongst neonates through a continuous active surveillance intervention. Methods: Fecal ESBL-KP cultures were performed weekly on all neonates over 4 years. Neonates with positive cultures were managed with contact precautions by dedicated nurses separately from other neonates. ESBL-KP acquisition amongst neonates staying >7 days was compared for the consecutive years. A subset of ESBL-KP isolates was typed with pulsed-field gel electrophoresis (PFGE). Results: Surveillance cultures were obtained from 1,482/1,763 (84%) neonates over 4 years. ESBL-KP acquisition decreased continuously from 94/397 (24%) neonates in 2006 to 33/304 (11%) in 2009 (p < 0.001, hazard ratio 0.75, 95% confidence interval 0.66–0.85, p < 0.001 for comparison of years). Hospital-wide ESBL-KP acquisition did not decrease outside the NICU. PFGE identified identical ESBL-KP strains from multiple neonates on six occasions and different strains from single neonates on seven occasions. Conclusions: ESBL-KP is probably both imported into and spread within the NICU. Continuous long-term surveillance with cohorting was associated with a decrease in ESBL-KP acquisition within the NICU. This low-risk intervention should be considered as a means to decrease neonatal acquisition of resistant bacteria.

© 2012 S. Karger AG, Basel




Related Articles:


References

  1. Edwards CA, Parrett AM: Intestinal flora during the first months of life: new perspectives. Br J Nutr 2002;88(suppl 1):S11–S18.
  2. Mackie RI, Sghir A, Gaskins HR: Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999;69:1035S–1045S.
  3. Siegel JD, Rhinehart E, Jackson M, Chiarello L: 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control 2007;35(10 suppl 2):S65–S164.
    External Resources
  4. Murray PR, Baron EJ: American Society for Microbiology. Manual of Clinical Microbiology, ed 8. Washington, ASM Press, 2003.
  5. Wiegand I, Geiss HK, Mack D, Sturenburg E, Seifert H: Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 2007;45:1167–1174.
  6. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, et al: Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006;3:59–67.
  7. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.
  8. Cohen MJ, Block C, Levin PD, Schwartz C, Gross I, Weiss Y, et al: Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective. Infect Control Hosp Epidemiol 2011;32:673–678.
  9. Abramson JH: WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004;1:6.
  10. Tamma PD, Savard P, Pal T, Sonnevend A, Perl TM, Milstone AM: An outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2012;33:631–634.
  11. Harbarth S, Sudre P, Dharan S, Cadenas M, Pittet D: Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 1999;20:598–603.
  12. Heinrich N, Mueller A, Bartmann P, Simon A, Bierbaum G, Engelhart S: Successful management of an MRSA outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 2011;30:909–913.
  13. Lepelletier D, Corvec S, Caillon J, Reynaud A, Roze JC, Gras-Leguen C: Eradication of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: which measures for which success? Am J Infect Control 2009;37:195–200.
  14. Saiman L, Cronquist A, Wu F, Zhou J, Rubenstein D, Eisner W, et al: An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24:317–321.
  15. Huang YC, Su LH, Wu TL, Leu HS, Hsieh WS, Chang TM, et al: Outbreak of Acinetobacter baumannii bacteremia in a neonatal intensive care unit: clinical implications and genotyping analysis. Pediatr Infect Dis J 2002;21:1105–1109.
  16. Pessoa-Silva CL, Meurer MB, Camara A, V, Flannery B, Almeida Lins MC, Mello Sampaio JL, et al: Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J Hosp Infect 2003;53:198–206.
  17. Anderson B, Nicholas S, Sprague B, Campos J, Short B, Singh N: Molecular and descriptive epidemiologyof multidrug-resistant Enterobacteriaceae in hospitalized infants. Infect Control Hosp Epidemiol 2008;29:250–255.
  18. Mammina C, Di Carlo P, Cipolla D, Giuffre M, Casuccio A, Di G, V, et al: Surveillance of multidrug-resistant Gram-negative bacilli in a neonatal intensive care unit: prominent role of cross-transmission. Am J Infect Control 2007;35:222–230.
  19. Singh N, Patel KM, Leger MM, Short B, Sprague BM, Kalu N, et al: Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr Infect Dis J 2002;21:1029–1033.
  20. Millar M, Philpott A, Wilks M, Whiley A, Warwick S, Hennessy E, et al: Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom. J Clin Microbiol 2008;46:560–567.
  21. Toltzis P, Dul MJ, Hoyen C, Salvator A, Walsh M, Zetts L, et al: The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit. Pediatrics 2002;110:707–711.
  22. Gregory ML, Eichenwald EC, Puopolo KM: Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics 2009;123:e790–e796.
  23. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, et al: Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000;356:1307–1312.
  24. Otter JA, Yezli S, French GL: The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011;32:687–699.
  25. Siegel JD, Rhinehart E, Jackson M, Chiarello L: Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(10 suppl 2):S165–S193.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: May 10, 2012
Accepted: September 03, 2012
Published online: December 11, 2012
Issue release date: February 2013

Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 2

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP